Evidence map›Paper›PMID 34174863›Full record

ArticleBMC musculoskeletal disorders2021

Debridement and corpectomy via single posterior approach to treat pyogenic spondylitis after vertebral augmentation.

Shuai Zhang, Song Wang, Qing Wang, Jin Yang, Shuang Xu

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shuai Zhang *Department of Orthopedics, The Affiliated Hospital of Southwest Medical University, NO. 25 Taiping Street, Sichuan, 646000, Luzhou City, China.
Song WangDepartment of Orthopedics, The Affiliated Hospital of Southwest Medical University, NO. 25 Taiping Street, Sichuan, 646000, Luzhou City, China. 839017957@qq.com.
Qing WangDepartment of Orthopedics, The Affiliated Hospital of Southwest Medical University, NO. 25 Taiping Street, Sichuan, 646000, Luzhou City, China.
Jin Yang *Department of Orthopedics, The Affiliated Hospital of Southwest Medical University, NO. 25 Taiping Street, Sichuan, 646000, Luzhou City, China.
Shuang XuDepartment of Orthopedics, The Affiliated Hospital of Southwest Medical University, NO. 25 Taiping Street, Sichuan, 646000, Luzhou City, China.
Affiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfection after vertebral augmentation (VA) often limits the daily activities of patients and even threatens their life. The operation may be one of the effective treatments if the patient suffers from intolerable severe pain, neurological deficits, and damage to spinal stability. This study aimed to investigate the clinical efficacy of the treatment of pyogenic spondylitis after vertebral augmentation (PSVA) with Single posterior debridement, vertebral body resection, and intervertebral bone graft fusion and internal fixation (sPVRIF).

methodsThe study was performed on 19 patients with PSVA who underwent VA at 4 hospitals in the region between January 2010 and July 2020. Nineteen patients were included. Among them, 16 patients underwent sPVRIF to treat the PSVA.

resultsA total of 2267 patients underwent VA at 4 hospitals in the region. Of the 19 patients with postoperative PSVA, suppurative spondylitis was misdiagnosed as an osteoporotic vertebral fracture(OVF) in 4 patients and they underwent VA. Besides osteoporosis, 18 patients had other comorbidities. The average interval between the first surgery and the diagnosis of PSVA was 96.4 days. Of the 19 patients, 16 received surgical treatment. The surgical time was 175.0±16.8 min, and the intraoperative blood loss was 465.6±166.0 mL. Pathogenic microorganisms were cultured in 12 patients.

conclusionPSVA is a severe complication that can even threaten the life of the patients. sPVRIF may be one of the effective treatments if the patient suffers from intolerable severe pain, neurological deficits, and damage to spinal stability.

Indexed as

Spinal FracturesSpinal FusionSpondylitisDebridementHumansLumbar VertebraeSpineThoracic VertebraeTreatment OutcomeClinical efficacyDebridementPyogenic spondylitisSingle posterior approachVertebral augmentation

Identifiers

PMID34174863
PMCPMC8236162
OpenAlexW3134163652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.